Home / Health / Dad's Cancer Drug Hope Given NHS Approval
Dad's Cancer Drug Hope Given NHS Approval
2 May
Summary
- A trial drug provided crucial extra time for a father.
- The patient saw his son celebrate his first birthday.
- The drug is now recommended for NHS use in Wales and England.
A groundbreaking trial drug has offered a glimmer of hope to families battling a rare and aggressive form of bile duct cancer. Huw Jones, diagnosed with Stage 4 cholangiocarcinoma, was given vital additional time with his family.
This extended period allowed him to witness a significant milestone: his son Idris celebrating his first birthday. Jones had actively campaigned for the drug's accessibility before his passing.
Following his advocacy, the National Institute for Health and Clinical Excellence (NICE) has now recommended the drug, Zanidatamab, for NHS use in Wales and England. This decision is expected to provide hope and extended life for many other patients.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
